Clinical implications of the immunomodulatory effects of macrolides.
about
Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.Azithromycin decreases crevicular fluid volume and mediator content.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Respiratory Infections in the U.S. Military: Recent Experience and ControlSuccessful treatment of chronic lower respiratory tract infection by macrolide administration in a patient with intralobar pulmonary sequestration and primary ciliary dyskinesia.Macrolides in chronic inflammatory skin disorders.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsInfluence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.Azithromycin reduces inflammation in a rat model of acute conjunctivitis.Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literatureEffect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.Azithromycin treatment increases survival of high-risk corneal allotransplants.Antibiotic use in the management of pulmonary nodulesBiotic acts of antibioticsEffects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta).Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma.Bugs and asthma: a different disease?Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line.Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes.Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages.Imipenem-cilastatin-induced psychosis: a case report.Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.Azithromycin attenuates acute radiation-induced lung injury in mice.Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis.
P2860
Q30379206-319A930C-3211-42D1-B6BA-1F1D8F462139Q33943151-A4C70B6F-DFC9-4619-9116-6026B4A0C52DQ34014517-50D80045-8782-473E-A083-8B59A0E6B927Q35070866-37EEF825-6A51-42BF-AB63-8124ACEABDB2Q35763405-9E55739F-FF77-4DED-A5C5-8C2FF7BA0973Q35849657-4003AE68-E49A-4279-910B-2C00E860FB35Q35997016-B8688006-4941-4D43-9E70-C2D08F8399C4Q36072425-205F3EAA-A66C-4CA2-839B-4BB2D9D82190Q36338455-5E45B028-DB62-4995-9114-6D6D52618B2AQ36574136-83BF2348-9030-4EE9-82F8-B769E2DE6889Q36640295-7938E1A6-CEC4-49C0-BD33-E18C01A3F785Q36723908-68E40478-A7DE-4037-BBE9-B4A85407F961Q36755971-D04D926B-0871-4FF0-A6BE-FAEE0AB32A5EQ37073812-328EE51C-5081-48AC-B9D5-5E0B84CFA97CQ37101851-8C203A8E-AD1B-4F3F-A8EA-9239CDCD0606Q37243876-028BBFD3-EDA3-4C82-A37B-D7C48A3D2C68Q37346840-657C2BEF-B87B-46F5-AA7F-E89B7B9D5586Q37455701-86A8C770-6E83-46D8-A5E0-652E23761455Q39181371-685060BD-03A6-407D-BA5D-D6F55B4F0262Q39320060-D8EDEBF3-B552-4271-902A-E07E9EDB3367Q39669137-64B404B5-C284-4ECF-8340-649CFC398419Q39778460-F0A957BA-FB8D-471C-BD6D-6EEBA6D74656Q39818833-2AA9C53E-A324-415F-8EB1-AC46FADA30F4Q40749683-6BA34882-E792-4DBA-A8DD-D4B7EE05C414Q43196038-A3319C04-B4BE-4DDB-86CA-3019991F7D84Q52721363-1EB02F29-D85A-42C1-8353-EB0483588476Q55410086-082A181A-1467-4A63-9E2F-9DF6A2B8AB7D
P2860
Clinical implications of the immunomodulatory effects of macrolides.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Clinical implications of the immunomodulatory effects of macrolides.
@ast
Clinical implications of the immunomodulatory effects of macrolides.
@en
type
label
Clinical implications of the immunomodulatory effects of macrolides.
@ast
Clinical implications of the immunomodulatory effects of macrolides.
@en
prefLabel
Clinical implications of the immunomodulatory effects of macrolides.
@ast
Clinical implications of the immunomodulatory effects of macrolides.
@en
P2093
P1476
Clinical implications of the immunomodulatory effects of macrolides.
@en
P2093
Hajime Takizawa
Jun Tamaoki
Junichi Kadota
P304
P407
P478
117 Suppl 9A
P577
2004-11-01T00:00:00Z